Application Notes & Case Studies

  1. The Michael J. Fox Foundation For Parkinson’s Research Works With Service Provider To Remove Reimbursement And Travel Obstacles For Clinical Study Participants 10/19/2020

    In 2010, MJFF launched a large-scale clinical study conducted at a network of clinical sites around the world focused on identifying and validating Parkinson’s disease biomarkers. The study realized it needed a new way to ensure that participants were remaining engaged throughout the long protocol and that the experience was as seamless as possible for both the volunteers and the site coordinators. They were able to source a solution to support patient-centricity, as well as study site efficiency.

  2. Delivering Clinical Trial Medications Direct-To-Patient 10/15/2020

    In a perfect world patients enrolled in clinical trials would live a short distance from the investigator site where they receive their treatment. Unfortunately that is not always the case. In recent years the Direct-to- Patient model, which brings medical procedures to a patient’s home, has emerged as a solution for Sponsors to increase patient recruitment and retention in clinical trials.

  3. Reinventing Neurodegenerative Protocols To Overcome COVID-19 Hurdles 10/13/2020

    A global, pivotal Phase III Alzheimer’s trial aiming to screen 6,000+ patients faced unforeseen challenges when the COVID-19 pandemic hit just a few months into recruitment. Finding a solution that provided proactive screening, assessment, and IP administration techniques enabled a new approach to collecting patient data and administering required IP and study visits which preserved the study integrity.

  4. Global Pharma Company Dramatically Improves Collaboration, Communication, And Compliance In Trials IQVIA Investigator Site Portal: An Enterprise Implementation 10/9/2020

    A Top 5 global pharmaceutical company wanted to streamline communications and ease the burden of manual tasks and repetitive training for sites. After evaluating several options, the company deployed IQVIA Technologies’ Investigator Site Portal (formerly DrugDev) for complete study conduct, utilizing its purpose-built Learning Management System (LMS), Document Exchange, and Site Engagement modules.

  5. eRegulatory: A Site's Perspective 9/28/2020

    Coastal Pediatric Research (CPR) was well aware of the eRegulatory trend that was surfacing. Before CPR selected a platform, the team gave some thought to what they wanted an eRegulatory system to contain and/or provide. Learn more about the criteria for their selection and what solution met their criteria.

  6. Home Health Nurse Network Ensures Patient Care Continuity During The COVID-19 Pandemic 9/10/2020

    Due to primary provider office closures, patients were unable to schedule their in-office subcutaneous injections required every six months. The client turned to UBC to design, structure and operationalize a program using our nationwide network of registered nurses, which would transition in-office visits to a supportive and effective in-home setting.

  7. Maintain Compliance With A Direct To Patient Via Site Drug Shipment Strategy 9/2/2020

    Developing a drug shipment strategy to introduce enhanced convenience to patients not only supports retention, but delivers added value to sponsors through improved supply chain continuity and end to end temperature controlled compliance. Download the case study to find out more.

  8. Mitigating COVID-19 Risks In A Complex, Fast-Moving Pain Program 8/19/2020

    A cutting-edge biotech was running a program with three active, concurrent, pain studies across 25 sites and 218 patients, with interim database locks scheduled during the summer of 2020 and final database lock deadlines looming close behind. The COVID-19 pandemic put that all on the line.

  9. A Global Observational Registry Of Adult Patients With Homozygous Familial Hypercholesterolemia (HoFH) 8/5/2020

    Clinical development service provider efficiently and strategically manages a global rare disease registry with rolling start-up, including mandated annual data collection and reporting.

  10. CRO Implements A Successful, Patient-Centric Decentralized Solution For An On-going Clinical Trial During COVID-19 8/3/2020

    A mid-sized biotech company was in the middle of conducting an open-label long-term safety study with 137 active patients across 25 sites in the US and Canada. Then the COVID-19 pandemic hit. Rho developed a customized and decentralized solution for their study that would ensure patient safety and data quality while allowing their study to progress according to FDA guidelines for conducting research during this pandemic.